These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 2791441)

  • 1. The future of automated record linkage for postmarketing surveillance: a response to Shapiro.
    Faich GA; Stadel BV
    Clin Pharmacol Ther; 1989 Oct; 46(4):387-9. PubMed ID: 2791441
    [No Abstract]   [Full Text] [Related]  

  • 2. Automated record linkage: a response to the commentary and letters to the editor.
    Shapiro S
    Clin Pharmacol Ther; 1989 Oct; 46(4):395-8. PubMed ID: 2791442
    [No Abstract]   [Full Text] [Related]  

  • 3. The role of automated record linkage in the postmarketing surveillance of drug safety: a critique.
    Shapiro S
    Clin Pharmacol Ther; 1989 Oct; 46(4):371-86. PubMed ID: 2535647
    [No Abstract]   [Full Text] [Related]  

  • 4. Record linkage for postmarketing surveillance.
    Faich GA
    Clin Pharmacol Ther; 1989 Oct; 46(4):479-80. PubMed ID: 2791451
    [No Abstract]   [Full Text] [Related]  

  • 5. Uninformed criticism of automated record linkage.
    Vick H; Walker AM
    Clin Pharmacol Ther; 1989 Oct; 46(4):478-9. PubMed ID: 2791450
    [No Abstract]   [Full Text] [Related]  

  • 6. Electronic Reporting for Clinical Drug Safety and Pharmacovigilance. 29 - 30 October 2002, Amsterdam, The Netherlands.
    Hennig R
    Expert Opin Drug Saf; 2003 Mar; 2(2):195-7. PubMed ID: 12904118
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Record linkage studies for postmarketing drug surveillance: data quality and validity considerations.
    Stergachis AS
    Drug Intell Clin Pharm; 1988 Feb; 22(2):157-61. PubMed ID: 3349931
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Automated data bases used for pharmacoepidemiology research.
    Strom BL; Carson JL
    Clin Pharmacol Ther; 1989 Oct; 46(4):390-4. PubMed ID: 2535648
    [No Abstract]   [Full Text] [Related]  

  • 9. Pharmacoepidemiology: the lessons learned; the challenges ahead.
    Tilson HH
    Clin Pharmacol Ther; 1989 Oct; 46(4):480. PubMed ID: 2791452
    [No Abstract]   [Full Text] [Related]  

  • 10. Automated record linkage.
    Friedman GD
    Clin Pharmacol Ther; 1990 Apr; 47(4):547-8. PubMed ID: 2328563
    [No Abstract]   [Full Text] [Related]  

  • 11. The role of record linkage in post-marketing drug surveillance.
    Crombie IK
    Br J Clin Pharmacol; 1986; 22 Suppl 1(Suppl 1):77S-82S. PubMed ID: 3567036
    [No Abstract]   [Full Text] [Related]  

  • 12. Identifying adverse reactions to drugs. Reporting systems.
    Stern RS
    Clin Dermatol; 1986; 4(1):15-22. PubMed ID: 2978679
    [No Abstract]   [Full Text] [Related]  

  • 13. Identification of adverse reactions to new drugs. IV--Verification of suspected adverse reactions.
    Venning GR
    Br Med J (Clin Res Ed); 1983 Feb; 286(6364):544-7. PubMed ID: 6402143
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The future of pharmacovigilance: a personal view.
    Edwards IR
    Eur J Clin Pharmacol; 2008 Feb; 64(2):173-81. PubMed ID: 18172624
    [No Abstract]   [Full Text] [Related]  

  • 15. Pharmacogenomic profiling in postmarketing surveillance: prospects and challenges.
    Issa AM
    Pharmacogenomics; 2003 Sep; 4(5):647-55. PubMed ID: 12943471
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Expanding roles of hospital epidemiology: pharmacoepidemiology.
    Burke JP; Tilson HH; Platt R
    Infect Control Hosp Epidemiol; 1989 Jun; 10(6):253-4. PubMed ID: 2661681
    [No Abstract]   [Full Text] [Related]  

  • 17. Postmarketing drug surveillance by record linkage in Tayside.
    Crombie IK; Brown SV; Hamley JG
    J Epidemiol Community Health; 1984 Sep; 38(3):226-31. PubMed ID: 6470600
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Drug-safety pilot makes the grade.
    Ledford H
    Nature; 2014 Sep; 513(7519):472. PubMed ID: 25254456
    [No Abstract]   [Full Text] [Related]  

  • 19. Post-marketing surveillance in the UK (1984).
    Lawson DH
    Br J Clin Pharmacol; 1986; 22 Suppl 1(Suppl 1):71S-75S. PubMed ID: 3567035
    [No Abstract]   [Full Text] [Related]  

  • 20. [Methods for drug safety monitoring: yesterday, today, tomorrow].
    Nazimkin KE; Ovchinnikova EA; Zhuravleva MV
    Antibiot Khimioter; 2007; 52(7-8):41-52. PubMed ID: 18986024
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.